CDH1 and breast carcinoma: In breast cancer cell lines, CCL18 derived from TAMs activates NF‐κB and thereby induces EMT‐like changes including spindle‐shaped morphology, E‐cadherin‐to‐vimentin switch, and increased invasive properties (Su et al., 2014).